These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38223808)

  • 1. Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials.
    Karimi SM; Bayat M; Rahimi R
    J Tradit Complement Med; 2024 Jan; 14(1):1-18. PubMed ID: 38223808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal medicines for treating osteoporosis.
    Liu Y; Liu JP; Xia Y
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD005467. PubMed ID: 24599707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs.
    Guo Y; Li Y; Xue L; Severino RP; Gao S; Niu J; Qin LP; Zhang D; Brömme D
    J Ethnopharmacol; 2014 Sep; 155(3):1401-16. PubMed ID: 25109459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of Herbal Medicine on Bone Mineral Density in Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Lin WL; Lin PY; Hung YC; Hsueh TP
    Am J Chin Med; 2020; 48(8):1749-1768. PubMed ID: 33308099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Herbal Medicine in Modulating Bone Homeostasis.
    Cheng X; Jin S; Feng M; Miao Y; Dong Q; He B
    Curr Top Med Chem; 2024; 24(7):634-643. PubMed ID: 38333981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms.
    Bina F; Soleymani S; Toliat T; Hajimahmoodi M; Tabarrai M; Abdollahi M; Rahimi R
    Pharmacol Res; 2019 Jan; 139():76-90. PubMed ID: 30412733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology.
    Liu C; Ma R; Wang L; Zhu R; Liu H; Guo Y; Zhao B; Zhao S; Tang J; Li Y; Niu J; Fu M; Zhang D; Gao S
    J Ethnopharmacol; 2017 Feb; 198():351-362. PubMed ID: 28111216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review.
    Yatoo MI; Gopalakrishnan A; Saxena A; Parray OR; Tufani NA; Chakraborty S; Tiwari R; Dhama K; Iqbal HMN
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):39-58. PubMed ID: 29336271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Nanotechnology to Improve Bone Health in Osteoporosis Exploiting
    Ahmad J; Albarqi HA; Ahmad MZ; Orabi MAA; Md S; Bandopadhyay R; Ahmed F; Khan MA; Ahamad J; Mishra A
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic and Mechanistic Approaches of
    Al-Bari MAA; Hossain S; Mia U; Al Mamun MA
    Curr Drug Targets; 2020; 21(16):1687-1702. PubMed ID: 32682372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitargeted combination effects of a triherbal formulation containing ELP against osteoporosis: in vitro evidence.
    Ko CH; Lau KM; Chau L; Cheung DW; Siu WS; Wong HL; Shum WT; Gao S; Fung KP; Leung PC; Poon SK; Lau CB
    J Pharm Pharmacol; 2016 Jun; 68(6):826-33. PubMed ID: 27019348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy isoflavones for osteoporosis: an evidence-based approach.
    Taku K; Melby MK; Nishi N; Omori T; Kurzer MS
    Maturitas; 2011 Dec; 70(4):333-8. PubMed ID: 21958941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.
    Kaur M; Nagpal M; Singh M
    Curr Drug Targets; 2020; 21(16):1640-1651. PubMed ID: 32735518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological agents and natural compounds: available treatments for osteoporosis.
    Martiniakova M; Babikova M; Omelka R
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health.
    Indran IR; Liang RL; Min TE; Yong EL
    Pharmacol Ther; 2016 Jun; 162():188-205. PubMed ID: 26820757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
    Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
    J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis.
    Zhang L; Li X; Ying T; Wang T; Fu F
    Front Endocrinol (Lausanne); 2021; 12():744647. PubMed ID: 34867788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidative hypoglycemic herbal medicines with in vivo and in vitro activity against C-reactive protein; a systematic review.
    Mirahmad M; Mohseni S; Tabatabaei-Malazy O; Esmaeili F; Alatab S; Bahramsoltani R; Ejtahed HS; Qulami H; Bitarafan Z; Arjmand B; Nazeri E
    Phytomedicine; 2023 Jan; 109():154615. PubMed ID: 36610136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.